Immunomedics Inc (NASDAQ:IMMU)

16.22
Delayed Data
As of Apr 25
 +0.14 / +0.87%
Today’s Change
5.15
Today|||52-Week Range
18.93
+0.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues9.0M5.7M3.2M3.1M
 
 
 
 
 
Cost of Goods Sold1.5M264.9K421.5K32.7K
 
 
 
 
 
Depreciation And Amortization569.4K578.1K737.7K900.0K
 
 
 
 
 
 
Operating ExpensesGross Income6.9M4.8M2.1M2.2M
 
 
 
 
 
General Expenses42.5M51.0M61.1M81.3M
 
 
 
 
 
Research And Development33.1M41.2M53.5M51.8M
 
 
 
 
 
Total Operating Expenses44.6M51.9M62.2M82.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-35.6M-46.2M-59.0M-79.1M
 
 
 
 
 
Extraordinary Charge0.000.000.00-68.7M
 
 
Interest Expense On Debt--2.1M5.5M5.5M
 
 
 
 
Other Expenses940.009.8K-37.5K-307.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-35.5M-48.1M-64.2M-153.2M
 
 
 
 
 
Income Taxes-7.8K-58.2K-5.1M-20.9K
 
 
 
 
 
Minority Interest-105.4K-121.6K-98.8K-60.3K
 
 
 
 
 
Net Income-35.4M-48.0M-59.0M-153.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS84.6M93.3M94.8M104.5M
 
 
 
 
 
Shares To Calculate EPS Diluted84.6M93.3M94.8M104.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.42-$0.51-$0.62-$1.47
 
 
 
 
 
EPS Diluted-$0.42-$0.51-$0.62-$1.47